146 related articles for article (PubMed ID: 6807193)
1. Valproate-induced hyperammonemia.
Batshaw ML; Brusilow SW
Ann Neurol; 1982 Mar; 11(3):319-21. PubMed ID: 6807193
[TBL] [Abstract][Full Text] [Related]
2. [Hyperammonemia in valproate therapy in children and adolescents].
Laub MC
Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
[TBL] [Abstract][Full Text] [Related]
3. [Hyperammonemias of childhood. I. Enzymopathies of the urea cycle].
Kopieczna-Grzebieniak E; Toborek M; Tarnawski R; Jakubowska D
Pediatr Pol; 1987 Oct; 62(10):727-32. PubMed ID: 3328149
[No Abstract] [Full Text] [Related]
4. [Role of hyperammonemia in stuporous states induced by sodium valproate].
Warter JM; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Koehl C; Imler M; Collard M
Rev Neurol (Paris); 1983; 139(12):753-7. PubMed ID: 6420866
[TBL] [Abstract][Full Text] [Related]
5. Siblings with carbamyl phosphate synthetase I deficiency.
Asanuma K; Takeuchi Y; Kanda M; Kikuchi Y; Yano N; Kakinuma H
Acta Pathol Jpn; 1984 Jul; 34(4):901-10. PubMed ID: 6485804
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral edema with hyperammonemia in valpromide poisoning. Manifestation in an adult, of a partial deficit in type I carbamylphosphate synthetase].
Bourrier P; Varache N; Alquier P; Rabier D; Kamoun P; Lorre G; Alhayek G
Presse Med; 1988 Nov; 17(39):2063-6. PubMed ID: 2974563
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of hyperammonemia in carbamyl phosphate synthase deficiency with peritoneal dialysis and venovenous hemofiltration].
Lettgen B; Bonzel KE; Colombo JP; Fuchs B; Kordass U; Wendel K; Rascher W
Monatsschr Kinderheilkd; 1991 Sep; 139(9):612-7. PubMed ID: 1745252
[TBL] [Abstract][Full Text] [Related]
8. Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma.
Verbiest HB; Straver JS; Colombo JP; van der Vijver JC; van Woerkom TC
Acta Neurol Scand; 1992 Sep; 86(3):275-9. PubMed ID: 1414247
[TBL] [Abstract][Full Text] [Related]
9. [Remarks on a clinical case of partial carbamyl phosphate synthetase deficiency].
Gomirato G; Giaretto G; Bonomi A; Rossi E; Rovere A; Radeschi G; Crosato M
Minerva Pediatr; 1989 Feb; 41(2):105-8. PubMed ID: 2739630
[TBL] [Abstract][Full Text] [Related]
10. Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.
Ratnaike RN; Schapel GJ; Purdie G; Rischbieth RH; Hoffmann S
Br J Clin Pharmacol; 1986 Jul; 22(1):100-3. PubMed ID: 3091053
[TBL] [Abstract][Full Text] [Related]
11. [Late diagnosis of congenital argininemia during administration of sodium valproate].
Christmann D; Hirsch E; Mutschler V; Collard M; Marescaux C; Colombo JP
Rev Neurol (Paris); 1990; 146(12):764-6. PubMed ID: 2291040
[TBL] [Abstract][Full Text] [Related]
12. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
[TBL] [Abstract][Full Text] [Related]
13. [Comments on the contribution, Therapy of hyperammonemia in carbamylphosphate synthetase deficiency with peritoneal dialysis and venovenous hemofiltration, by B. Lettgen et al].
Brockstedt M
Monatsschr Kinderheilkd; 1992 Jul; 140(7):431. PubMed ID: 1308100
[No Abstract] [Full Text] [Related]
14. [Alterations of the state of consciousness induced by valproic acid: 6 case reports].
Campostrini R; Paganini M; Boncinelli L; Zaccara G; Arnetoli G; Zappoli R
Riv Patol Nerv Ment; 1983; 104(1):23-34. PubMed ID: 6431599
[TBL] [Abstract][Full Text] [Related]
15. Severe neonatal deficiency of carbamylphosphate synthetase.
Lambotte C; Adam A; Van Der Hofstadt J; Dodinval-Versie J; Gielen J
Acta Paediatr Belg; 1977; 30(3):151-5. PubMed ID: 204150
[No Abstract] [Full Text] [Related]
16. [Hyperammonemia].
Arashima S
Nihon Rinsho; 1978 May; Suppl():1352-3. PubMed ID: 691351
[No Abstract] [Full Text] [Related]
17. Successful treatment of severe carbamyl phosphate synthetase I deficiency.
Van de Bor M; Mooy P; van Zoeren D; Berger R; van Gelderen HH; Teijema HL
Arch Dis Child; 1984 Dec; 59(12):1183-5. PubMed ID: 6524951
[TBL] [Abstract][Full Text] [Related]
18. Kinetic abnormalities of carbamyl phosphate synthetase-I in a case of congenital hyperammonaemia.
Qureshi IA; Letarte J; Ouellet R; Lemieux B; Cathelineau L
J Inherit Metab Dis; 1986; 9(3):253-60. PubMed ID: 3099069
[TBL] [Abstract][Full Text] [Related]
19. Carbamylphosphate synthetase-I deficiency in a newborn: survival after early diagnosis and therapy.
Raghavan K; Chabra S; Mondkar J; Aiyar R; Ambani LM; Fernandez A
Indian Pediatr; 1991 May; 28(5):551-4. PubMed ID: 1752685
[No Abstract] [Full Text] [Related]
20. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?
Kondo T; Ishida M; Kaneko S; Hirano T; Otani K; Fukushima Y; Muranaka H; Koide N; Yokoyama M; Nakata S
Epilepsia; 1992; 33(3):550-4. PubMed ID: 1350534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
